Exercise News and Research

Latest Exercise News and Research

Interleukin Genetics to present new genetic findings on obesity and osteoporosis

Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it will present new genetic findings in the fields of obesity and osteoporosis at medical meetings later this month.

13 Oct 2009

Renowned physicians encourage women to go for regular breast examinations

Doctors Ritu Chopra and Andrew Ordon, respected physicians with practices in Rancho Mirage and Beverly Hills, are encouraging Coachella Valley women to obtain regular breast exams and to be aware of their general breast health.

13 Oct 2009

Neighborhood may be a modifiable risk factor for diabetes

Individuals living in neighborhoods conducive to physical activity and providing access to healthy foods may have a lower risk of developing type 2 diabetes in a five-year period, according to a report in the October 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Oct 2009

Strengthen key muscles in the foot to improve overall performance

With summer weather finally gone, more Canadians will spend hours at the gym sculpting their muscles, but most will neglect one of the most important ones - the foot. Recent studies show neglecting the feet leads to chronic foot, knee, back, and joint pain. By strengthening key muscles in the foot, a person can improve their overall performance, energy and pain.

13 Oct 2009

Cox's initiative to safeguard the community at-large

Recognized as a leader in serving its customers with state-of-the-art cable, broadband and entertainment services, Cox will soon broaden its local impact by safeguarding the community at-large. On October 30, 2009, Cox will be the first and only private corporation to operate as one of three Orange County locations to conduct an Orange County Health Care Agency (OCHCA) Point-Of-Dispensing (POD) at its Rancho Santa Margarita headquarters.

13 Oct 2009

Legendary coach helps raise awareness on osteoarthritis

After leading the U.S. men’s basketball team to Olympic gold last year and two weeks before the start of his 30th season as head coach of Duke University’s men’s basketball team, Mike Krzyzewski (Coach K), 61, is teaming up with the Arthritis Foundation to help raise awareness of the disease that nearly ended his coaching career 10 years ago.

13 Oct 2009

Comprehensive weight management system from EIRO Research

EIRO Research, a Dallas-based nutritional company, launched EIROfit, a comprehensive and easy-to-use weight management system, at its launch convention on October 9, 2009.

13 Oct 2009

Underwriters exercise their over-allotment option in purchasing additional Stereotaxis' shares

Stereotaxis, Inc. announced today that the underwriters for the recently announced public offering of Stereotaxis common stock have exercised in full their over-allotment option to purchase an additional 975,000 shares of the Company's common stock. The 7,475,000 shares of Stereotaxis common stock in the offering, including the 975,000 shares subject to the over-allotment option, are being sold at a price to the public of $4.00 per share.

12 Oct 2009

OXIS International to raise $2.0 million from sale of Convertible Debentures and Warrants

OXIS INTERNATIONAL, INC. announced today that the Company has entered into and closed agreements with several accredited investors to purchase Convertible Debentures and Warrants representing $2.0 million in gross proceeds.

12 Oct 2009

Arena Pharmaceuticals to present Phase 3 BLOSSOM trial results at Obesity 2009

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that lorcaserin will be featured in multiple presentations at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society in Washington, DC.

12 Oct 2009

The Hallowell Centers include beneficial exercises in treatment of ADHD

New brain research is unlocking long-standing mysteries, explaining how the brain trains itself and how human beings develop their superior cognitive skills. New scanning tools (FMRI, SPECT, QEEG, etc.) are advancing neurology's understanding of a process called neuroplasticity and shedding light on a simple looking balance and movement regimen used since 1982 by developmental specialists to treat people with ADHD, Dyslexia and other learning differences.

12 Oct 2009

XTend Medical provides update regarding the BioHarp market potential

XTend Medical, a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following information regarding the BioHarp market potential.

12 Oct 2009

Noveko International closes initial amount of $11.7 million private placement

Noveko International Inc. ("the Company") is pleased to announce the closing of an initial amount of $11.7 million (the "first Closing") of its previously announced best efforts private placement (the "Offering"). It is expected that a second and final closing of the Offering will occur no later than October 30, 2009.

12 Oct 2009

Santarus and Norgine enter into a licensing agreement for ZEGERID products

Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.

12 Oct 2009

COPD Management Program for South Region TRICARE beneficiaries

Humana Military Healthcare Services, a wholly owned subsidiary of Humana Inc., announced today an additional benefit available for South Region TRICARE beneficiaries. The Chronic Obstructive Pulmonary Disease (COPD) Management Program offers telephonic education and coaching by dedicated registered nurses.

12 Oct 2009

Results of Phase 2a clinical trial of DR Cysteamine announced by Raptor Pharmaceutical

Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.

12 Oct 2009

Federal grant to boost food and feed safety initiatives

The U.S. Food and Drug Administration today announced that it has awarded 83 grants in FY2009 totaling $17.5 million to state and local regulatory agencies to boost food and feed safety initiatives among federal, state, and local partners.

12 Oct 2009

Supervised strength training makes the athletes perform much better

Half of all Swedish elite volleyball players suffer at least one injury per season. One important reason may be that most players perform injury-preventing strength training unsupervised. This is shown in a new thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

12 Oct 2009

Doctors and scientists form national pain research centre

An expert network of doctors and research scientists is forming the world's first national centre for research into understanding pain in arthritis. Backed by medical research charity the Arthritis Research Campaign and The University of Nottingham, it will aim to improve treatments for arthritis - the most common cause of chronic pain - which affects more than ten million people in the UK.

12 Oct 2009

WCMC-Q program highlights the importance of mental health to overall physical health

Mental health professionals from Weill Cornell Medical College in Qatar and the community highlighted the importance of mental health to overall physical health during a presentation Sunday as part of the medical college's recognition of World Mental Health Day.

12 Oct 2009